SeptanestĀ® SP

Gold standard pain management for all procedures.

precision

Terminal sterilization

Clean

Paraben free and no natural rubber latex

Safety

Anesthesia for all procedures

  • Indications

    • Local or loco-regional dental anesthesia in patients of at least 4 years old
  • Features & benefits

    • Fast onset to avoid delay before effective analgesia is achievedĀ 
    • No-methylparaben formulation to avoid allergic reactions on sensitive patientsĀ 
    • Latex-free plungers and sealsĀ 
    • High epinephrine concentration to improve blood control on the procedureā€™s siteĀ 
    • Terminal sterilization of product/cartridges for safe useĀ 
    • Mylar label covered glass cartridges to minimize risk of wound in the event of a cartridge breakageĀ 
  • Ordering information

    • Item #99145: Box containing 50 cartridges x 1.7 mlĀ 
  • Safety information

    • SeptanestĀ® SP is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. SeptanestĀ® SP with epinephrine 1:100,000 is preferred during operative or surgical procedures when improved visualization of the surgical field is desirable. Reactions to SeptanestĀ® SP (pain and headache, for example, or convulsions or respiratory arrest following accidental intravascular injection) are characteristic of those associated with other amide-type local anesthetics. SeptanestĀ® SP contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Accidental intravascular injection may be associated with convulsions, followed by central nervous system or cardiorespiratory depression and coma, progressing ultimately to respiratory arrest. Dental practitioners and/or clinicians who employ local anesthetic agents should be well versed in diagnosis and management of emergencies that may arise from their use. Resuscitative equipment, oxygen, and other resuscitative drugs should be available for immediate use. SeptanestĀ® SP, along with other local anesthetics, is capable of producing methemoglobinemia. The clinical signs of methemoglobinemia are cyanosis of the nail beds and lips, fatigue and weakness. If methemoglobinemia does not respond to administration of oxygen, administration of methylene blue intravenously 1-2 mg/kg body weight over a 5 minute period is recommended. Please see the Package Insert for prescribing information.Ā 
  • Documentation

Learn more about Septanest SP

Key figures about this product

6

Injections / second worldwide

0

No natural rubber latex - 0% methylparabens

You may wonder

  • Does SeptanestĀ® SP contain peanut, soy or nut?

    None of the ingredients of our product SeptanestĀ® SP are an evident source of peanut, soy or nut.

  • Does SeptanestĀ® SP contain gluten?

    None of the ingredients of our product SeptanestĀ® SP are an evident source of gluten.

  • Does SeptanestĀ® SP contain alcohol?

    None of the ingredients of our product SeptanestĀ® SP are an evident source of alcohol.

product-faqs

You may also need

Register for free
1/4 Choose your login information

Your password must contain at least:

8 characters

A number and a letter

A special character

2/4 Enter your personal information
4/4 Confirm

Register for free

Sign up now and get an exclusive access to:

  • Live webinars and webinar replays to learn from the best speakers in dentistry.
  • Educational content in a variety of formats (articles, podcasts, clinical cases, videos, and more) to enhance your skills and achieve business success.
  • Our Voice of Customer program to contribute in creating innovative products that address your needs.
Create an account
Sign up now Already a member? Log-in!
Forgot your password?

Enter your email address below.

We will send you a password reset link by email.

Cancel
Subscribe to our Newsletter